Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 4,800 shares at $28.44 ($137K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $137k DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |